A study from the CAS Key Laboratory of Innate Immunity and Chronic Disease, Innovation Center for Cell Signaling Network, School of Life Sciences, University of Science & Technology of China, Hefei, Anhui 230027, China; Scientific and Educational Department, The second hospital of Anhui Medical University, Hefei, Anhui. 230061, China shows that “MiR-181a regulates lipid metabolism via IDH1.” This study was published in the 5 March 2015 issue of the Journal “Scientific Reports” by Prof Wu, Chu B, and others.
On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: MiRNA-based therapy for Lipid metabolism disorders: p-ΔNp63α inhibits the expression of IDH1 and lipid accumulation via up regulation of its target gene miRNA-181a
Significance: Given that: (1) more than two billion adults are overweight globally; (2) 64% of US population is Overweight; and (3) the risk of death raises by 20-40% among overweight people, there is an urgent need to find an effective therapy for treating disorders associated with overweight.
This study suggests, for the first time, that p-ΔNp63α, by increasing the expression of its target gene miRNA-181a, it may inhibit the expression of IDH1 (Isocitrate dehydrogenase), a component of TCA cycle. Thereby, it may decrease and increase the expression of genes that promote lipid biosynthesis and β-oxidation, respectively. This, in turn, results in inhibition of lipid accumulation. Thus, pharmacological formulations encompassing “p-ΔNp63α activators or small molecule compounds that increase the expression of both p-ΔNp63α and miRNA-181a” may be used (1) to lower body weight; and (2) in the management of obesity disorders.
Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Web: http://genomediscovery.org
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
To cite: Boominathan, MiRNA-based therapy for Lipid metabolism disorders: p-ΔNp63α inhibits the expression of IDH1 and lipid accumulation via up regulation of its target gene miRNA-181a, 9/April/2015, 13.32, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
* Research cooperation